Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin- releasing hormone antagonist protocol in combination with a "freeze- all" strategy: A prospective multicentric study

Fertility and Sterility

Volumn 95, Issue 6, 2011, Pages

  Griesinger, Georg ^a,f   Schultz, Laura ^a   Bauer, Thomas ^b   Broessner, Anke ^c   Frambach, Thorsten ^d   Kissler, Stefan ^e  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b IVF Zentrum Augsburg   (Germany)

^c UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e Interdisziplinäres Kinderwunschzentrum   (Germany)

^f Campus Luebeck ^*  (Germany)

Author keywords

agonist triggering; frozen thawed embryo replacement cycle; GnRH agonist; GnRH antagonist; ovarian hyperstimulation syndrome (OHSS)

Indexed keywords

GONADORELIN ANTAGONIST; TRIPTORELIN;

ADULT; ARTICLE; BIRTH RATE; CELL SURVIVAL; CLINICAL TRIAL; CRYOPRESERVATION; DISEASE SEVERITY; EMBRYO REPLACEMENT CYCLE; FEMALE; FREEZE THAWING; HUMAN; INCIDENCE; LIVE BIRTH; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PRONUCLEUS; RISK ASSESSMENT; SLOW COOLING; VITRIFICATION; ZYGOTE;

EID: 79954988975     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.01.163     Document Type: Article

References (15)

1. B.C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, and J. Itskovitz-Eldor Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 87 2001 709 715
2. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
3. D. Bodri, J.J. Guillén, A. Galindo, D. Mataró, A. Pujol, and O. Coll Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study Fertil Steril 91 2009 365 371
4. M.A. Youssef, F. Van der Veen, H.G. Al-Inany, G. Griesinger, M.H. Mochtar, and M. van Wely Gonadotropin-releasing hormone agonist versus hCG for oocyte triggering in antagonist assisted reproductive technology cycles Cochrane Database Syst Rev 11 2010 CD008046
5. G. Griesinger, S. von Otte, A. Schroer, A.K. Ludwig, K. Diedrich, and S. Al-Hasani Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study Hum Reprod 22 2007 1348 1352 (Pubitemid 47062805)
6. P. Humaidan, E.G. Papanikolaou, and B.C. Tarlatzis GnRHa to trigger final oocyte maturation: a time to reconsider Hum Reprod 24 2009 2389 2394
7. O. Nevo, T. Eldar-Geva, S. Kol, and J. Itskovitz-Eldor Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin Fertil Steril 79 2003 1123 1128 (Pubitemid 36547849)
8. R. Babayof, E.J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, and M. Gal Serum inhibin A, VEGF and TNF{alpha} levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial Hum Reprod 21 2006 1260 1265
9. G. Griesinger, K. Diedrich, P. Devroey, and E.M. Kolibianakis GnRH-agonist for triggering final oocyte maturation in the GnRH-antagonist ovarian hyperstimulation protocol: systematic review and meta-analysis Hum Reprod Update 12 2006 159
10. G. Griesinger, K. Diedrich, B. Tarlatzis, and E.M. Kolibianakis GnRH-antagonists in ovarian stimulation for IVF in patients with [1] poor response to gonadotrophins, [2] polycystic ovary syndrome, and [3] risk of ovarian hyperstimulation: a meta-analysis Reprod BioMed Online 13 2006 628 638 (Pubitemid 44760885)
11. E. Chun Severe OHSS can be prevented in GnRH antagonist protocol using GnRHa to trigger ovulation Fertil Steril 84 Suppl 1 2005 S301
12. A. Golan, R. Ron-El, and A. Herman Ovarian hyperstimulation syndrome: an update review Obstet Gynecol Surv 44 1989 430 440 (Pubitemid 19138981)
13. A. Golan, and A. Weissman A modern classification of OHSS Reprod BioMed Online 19 2009 28 32
14. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, and H.M. Fatemi Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120 (Pubitemid 43063432)
15. S. Al-Hasani, B. Ozmen, N. Koutlaki, B. Schoepper, K. Diedrich, and A. Schultze-Mosgau Three years of routine vitrification of human zygotes: is it still fair to advocate slow-rate freezing? Reprod BioMed Online 14 2007 288 293 (Pubitemid 46463625)